Globe Life Inc. GL
At closeNov 6, 2026, 4:05 PM EST
After hours · Nov 6, 4:05 PM ET
- YTD
- +12.38%
- 1 year
- +19.23%
- Market cap
- 11.86B
- Revenue (ttm)
- 6.27B
- Profit margin
- 18.89%
- EPS (ttm)
- 14.94
- Shares out
- 75.44M
- P/E ratio
- 10.52
- Forward P/E
- 9.60
- Dividend
- 1.32 (0.83%)
- Ex-dividend date
- Oct 4, 2026
- YTD return
- +12.38%
- 1-year return
- +19.23%
- Volume
- 475.45K
- Avg volume
- 511.54K
- Open
- 157.38
- Previous close
- 159.21
- Day's range
- 156.82 – 158.35
- 52-week range
- 130.37 – 186.02
- Beta
- 0.46
- Analysts
- Buy
- Price target
- 185.18 (+17.8%)
- Earnings date
- Feb 3, 2027
5D -2.69 (-1.68%)
Key statistics
- Enterprise value
- 15.10B
- PEG ratio
- 1.30
- Price / sales
- 1.89
- Price / book
- 1.81
- Dividend yield
- 0.83%
- Payout ratio
- 8.43%
- Revenue growth
- 5.50%
- Free cash flow
- 1.49B
- Total cash
- 353.16M
- Total debt
- 3.45B
- Return on equity
- 19.26%
- Short % of float
- 0.05%
- 50-day average
- 167.23
- 200-day average
- 160.12
Analyst view
Consensus: buy
- Target (low)
- 161.00
- Target (mean)
- 185.18
- Target (high)
- 215.00
- Strong buy3
- Buy4
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 3, 2027
Expected Feb 3, 2027. Consensus EPS estimate 3.61.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 3, 2027 | Dec 30, 2026 | 3.60 | — | — | — |
| Oct 21, 2026 | Sep 30, 2026 | 4.90 | 4.84 | -0.06 | -1.22% |
| Jul 22, 2026 | Jun 30, 2026 | 3.67 | 3.61 | -0.06 | -1.63% |
| Apr 22, 2026 | Mar 31, 2026 | 3.47 | 3.43 | -0.04 | -1.15% |
| Feb 4, 2026 | Dec 31, 2025 | 3.44 | 3.39 | -0.05 | -1.45% |
| Oct 22, 2025 | Sep 30, 2025 | 4.60 | 4.81 | +0.21 | +4.57% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 23, 2026 | Piper Sandler | down | Overweight | Neutral |
| Oct 23, 2026 | Evercore ISI Group | main | In-Line | In-Line |
| Oct 23, 2026 | TD Cowen | main | Buy | Buy |
| Oct 15, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 12, 2026 | Wells Fargo | main | Overweight | Overweight |
About Globe Life Inc.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
- Sector
- Financial Services
- Industry
- Insurance - Life
- Country
- United States
- Website
- home.globelifeinsurance.com
News
Globe Life Inc. (GL) – What Are Researchers Thinking About This Stock? 
Evercore ISI Group Maintains In-Line on Globe Life, Lowers Price Target to $174 
TD Cowen Maintains Buy on Globe Life, Lowers Price Target to $215 
This Avalo Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday 
Piper Sandler Downgrades Globe Life to Neutral, Lowers Price Target to $165 
Globe Life Q3 2026 Earnings Call Transcript 
Globe Life Q3 Adj. EPS $4.84 Misses $4.88 Estimate, Sales $1.596B Beat $1.538B Estimate - JP Morgan Maintains Overweight on Globe Life, Raises Price Target to $195
Wells Fargo Maintains Overweight on Globe Life, Raises Price Target to $191 
Morgan Stanley Maintains Overweight on Globe Life, Lowers Price Target to $197
Your note
Sign in to keep a note on GL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADDISON LINDA L. | Director | Stock Award(Grant) | Jan 1, 2026 | 20,406 |
| ALEXANDER MARILYN A | Director | Stock Award(Grant) | Jan 1, 2026 | 22,606 |
| DARDEN JAMES MATTHEW | Chief Executive Officer | Sale | Jul 30, 2026 | 62,653 |
| HAWORTH JENNIFER ALLISON | Officer | Stock Award(Grant) | Feb 26, 2026 | 23,769 |
| KALMBACH THOMAS PETER | Chief Financial Officer | Sale | Jul 29, 2026 | 51,726 |
| MAJORS MICHAEL CLAY | Officer | Sale | Oct 22, 2026 | 39,141 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.33% | 5,528,883 | 869.44M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.73% | 5,080,734 | 798.97M | Jun 29, 2026 |
| Invesco Ltd. | 6.12% | 4,619,219 | 726.40M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.54% | 4,181,598 | 657.58M | Jun 29, 2026 |
| State Street Corporation | 4.95% | 3,735,409 | 587.41M | Jun 29, 2026 |
| Pzena Investment Management LLC | 4.61% | 3,479,093 | 547.10M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.27% | 2,464,519 | 387.56M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.67% | 2,011,077 | 316.25M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.36% | 1,780,297 | 279.96M | Jun 29, 2026 |
| AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund | 1.88% | 1,416,810 | 222.80M | Jul 30, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.53% | 1,151,905 | 181.14M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.50% | 1,128,004 | 177.38M | Jun 29, 2026 |